Nitric Oxide Status in Children with Chronic Kidney Disease. | ||||
| GEGET | ||||
| Article 3, Volume 15, Issue 1, June 2020, Page 17-22 PDF (309.54 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/geget.2020.21225.1009 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ahmed Hassan   1; Maged Affifi 2; Azza A Saab3
| ||||
| 1Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt. | ||||
| 2Pediatrics’ Hospital, Ain Shams University, Faculty of Medicine, Cairo, Egypt. | ||||
| 3Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. | ||||
| Abstract | ||||
| Introduction Children with chronic kidney disease (CKD) are at increased risk of cardiovascular (CVD) morbidity and mortality. Decreased production or reduced bioavailability of nitric oxide (NO) can augment such complications. Aim of the study To assess the levels of Nitric Oxide in the serum of chronic kidney disease children. Methods Case-control cross sectional study was conducted on 55 children as a stratified non-random sample; 30 with CKD on regular hemodialysis (HD) (Group I), 10 with CKD on conservative therapy (Group II) and 15 healthy children (Group III). Results Children with CKD whether on regular HD or on conservative therapy had significant lower serum NO levels (0.5 ± 0.2 and 2.1 ± 0.5 ng/ml respectively) as compared to healthy controls (9.8 ± 0.9 ng/ml; p < 0.001). Serum NO has significant negative correlations with duration of hemodialysis and with hypertension in Group I. Conclusions Nitric Oxide production is decreased in children with CKD, further decrease with the progression of the disease and correlated with hypertension and duration of hemodialysis. | ||||
| Keywords | ||||
| Chronic renal failure; End stage renal disease; Hemodialysis; Nitric oxide | ||||
|
Statistics Article View: 209 PDF Download: 222 |
||||
